| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.091 | 0.1 |